The contradictory function of IGF2BP1 in colon cancer cells and mouse models of colitis-associated cancer may result from use of different tumor models or the complexity of colon cancer tumorigenesis, suggesting that tumor cells arrived from different origins or conditions might have different responses to IGF2BP1 expression. This evidence concerns the gene IGF2BP1 and malignant colon neoplasm.